… Compared with CMS, the MSCPM-III stent used in this study has advantages that include …
sodium caprate. We therefore expected MSCPM-III to be superior to CMS in terms of stent …

… This new generation paclitaxel-eluting biliary stent is further endowed with sodium caprate
(MSCPM-III) for enhanced drug delivery. The purpose of this study is to examine the safety of …

… drug-eluting stents, sodium caprate was … stent was coated with a mixture containing sodium
caprate, paclitaxel, and polyurethane via the rolling coating technique. The coated stent has …

… : Metallic stents for malignant biliary obstruction are susceptible to occlusion by tumor ingrowth
or overgrowth. Thus, we previously reported a metallic stent … stent using a sodium caprate …

… This stent released paclitaxel for 2 months. In the multilayered cell sheet model, the amount
… with the sodium caprate containing PU membrane was twice that with the sodium caprate-…

… compared the efficacy of paclitaxel-eluting biliary metal stents with sodium caprate (n = 54)
and covered metal stents (n = 51) in the setting of malignant biliary obstructions. Although …

… vascular or non-vascular stenting is often limited by in-stent restenosis, resulting in failure
of existing stent or reintervention by use of another stent. Coronary drug-eluting stents (DESs) …

… and modified a new-generation stent, a metallic stent covered with a paclitaxel-incorporated …
Therefore, a new stent has been developed with the addition of sodium caprate to aid in …

… An antitumor drug/esophagus stent combination can … /esophagus stent combination: a
magnetocaloric nitinol stent coated … into esophagus wall from the PTX/nitinol stent combination. …

… the function of the stent in an … stent and the silicone tube with a stent equipped with a pH
sensor. (C) The real time measurement of pH level in the silicone tube equipped with a stent…